Posttraumatic stress disorder

Rapid Therapeutic Explores Treatment of Anxiety Utilizing Proprietary Delivery System for Psilocybin and CBD

Retrieved on: 
Wednesday, June 10, 2020
Psychiatry, Psychiatric diagnosis, Abnormal psychology, RTT, Medicine, Articles, Aftermath of war, Posttraumatic stress disorder, Anxiety disorder, Psilocybin, Coronavirus

About Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL)

Key Points: 
  • About Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL)
    RTSL markets its MDI products directly to pharmacies and physicians who treat GAD, PTSD and other stress and anxiety disorders.
  • RTSL currently does not sell any psilocybin products and is only testing pulmonary delivery geometry of its formulations with limited pre-clinical trials.
  • We encourage all customers to do their own research regarding cannabinoids, the use of MDIs and our products.
  • RTSL makes no claims about therapeutic benefits of its products and they do not treat coronavirus in any manner.

Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences

Retrieved on: 
Wednesday, June 3, 2020
RTT, Viruses, Articles, Medical specialties, Fibromyalgia, Posttraumatic stress disorder, Orthopoxvirus, Monkeypox, Biopharmaceutical, Smallpox, Tonix Pharmaceuticals

Tonixs current portfolio includes biologics to prevent infectious diseases, and small molecules and biologics to treat pain, psychiatric and addiction conditions.

Key Points: 
  • Tonixs current portfolio includes biologics to prevent infectious diseases, and small molecules and biologics to treat pain, psychiatric and addiction conditions.
  • TNX-801* (live horsepox virus vaccine for percutaneous administration) is in development to protect against smallpox and monkeypox.
  • Tonixs most advanced drug development programs are focused on delivering safe and effective long-term treatments for fibromyalgia, or FM, and posttraumatic stress disorder, or PTSD.
  • Tonixs most advanced product candidate, TNX-102 SL**, is in Phase 3 development as a bedtime treatment for fibromyalgia and PTSD.

Somatic Experiencing Trauma Institute Offers New Crisis Stabilization Toolkit For COVID-19 Response

Retrieved on: 
Monday, June 1, 2020
Articles, Health, Human behavior, Posttraumatic stress disorder, Stress, Adverse childhood experiences, Mental health, Psychological resilience, Self-sustainability, Somatic experiencing, Psychological trauma, Psychological stress

A primary feature is the SCOPESafety Aid (see attached graphic) that helps stabilize the physiological stress response and build resilience to get through crisis.

Key Points: 
  • A primary feature is the SCOPESafety Aid (see attached graphic) that helps stabilize the physiological stress response and build resilience to get through crisis.
  • The SCOPE toolbox, found at www.traumahealing.org/scope , also includes videos, Peer-to-Peer SECrisis Stabilization short programs, and links to practitioners trained to help, all as a feature of SETI's COVID-19 response efforts.
  • Because Somatic Experiencing is a neurobiological intervention technique, simple steps can help decompress stress responses and regulate the nervous system, releasing the 'stuck energy' of trauma."
  • The SETrauma Institute is a 501(c)(3) nonprofit organization dedicated to supporting trauma resolution and resilience and is a leading training institute for neurobiological intervention therapy.

NYSPA Announces Pro-Bono Trauma-Informed Therapy for Anyone Affected by COVID-19

Retrieved on: 
Thursday, May 28, 2020
Articles, Human behavior, Posttraumatic stress disorder, Humans, DRN, Psychological trauma, Rappoport

Under the initiative, any resident of New York state -- regardless of ability to pay -- may receive up to six free therapy sessions with some of New York's leading psychologists.

Key Points: 
  • Under the initiative, any resident of New York state -- regardless of ability to pay -- may receive up to six free therapy sessions with some of New York's leading psychologists.
  • The program, initiated by NYSPA President, Dr. Daniel Kaplin, and Disaster Relief Network (DRN) Chair, Dr. Evelyn Rappoport, is expected to attract a large number of applicants.
  • "These are unprecedented times, and nobody should be denied access to trauma treatment," noted Dr. Rappoport.
  • "Pandemics don't discriminate; trauma does not discriminate; and that is why we are here to serve people regardless of financial circumstance."

Research Report with COVID-19 Forecasts - Post-traumatic Stress Disorder Therapeutics Market 2020-2024 | Rising Prevalence of PTSD to Boost Growth | Technavio

Retrieved on: 
Monday, May 25, 2020
Pharmaceutical, Health, Mental health, Articles, Health, Human behavior, Stress, Adverse childhood experiences, Posttraumatic stress disorder, Military psychiatry, Veterans' affairs, Post-traumatic, Pfizer, Traumatic stress, Psychological trauma

Our post-traumatic stress disorder therapeutics market report covers the following areas:

Key Points: 
  • Our post-traumatic stress disorder therapeutics market report covers the following areas:
    This study identifies emerging therapies for PTSD treatment as one of the prime reasons driving the post-traumatic stress disorder therapeutics market growth during the next few years.
  • Post-traumatic Stress Disorder Therapeutics Market 2020-2024: Vendor Analysis
    We provide a detailed analysis of vendors operating in the post-traumatic stress disorder therapeutics market, including some of the vendors such as AstraZeneca Plc, Azevan Pharmaceuticals Inc., Bionomics Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, Mylan NV, Neurocrine Biosciences Inc., Novartis International AG, and Pfizer Inc.
  • Backed with competitive intelligence and benchmarking, our research reports on the post-traumatic stress disorder therapeutics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Post-traumatic Stress Disorder Therapeutics Market 2020-2024: Key Highlights

Buddy's Cannabis Teams With Invictus Foundation to Offer Medicinal Cannabis Therapies for Military-Related PTSD

Retrieved on: 
Thursday, May 21, 2020
Medicine, Aftermath of war, Military personnel, Veterans' affairs, Articles, Health, Abnormal psychology, Posttraumatic stress disorder, RTT, Medical cannabis, Veteran

The Invictus Foundation is continually exploring ways to continue to expand access to crucial treatment options and programs that assist veterans who are struggling with post-war illnesses.

Key Points: 
  • The Invictus Foundation is continually exploring ways to continue to expand access to crucial treatment options and programs that assist veterans who are struggling with post-war illnesses.
  • This includes making medical cannabis available to veterans and the well-being it can provide to them, states Peter J. Whalen, CEO of the Invictus Foundation.
  • To achieve our goal of expanding access and availability of medical grade cannabis to our military-related PTSD population the Invictus Foundation is partnering with Buddy's Cannabis in Renton.
  • We will partner with these CannaBusiness Associations to improve access, availability, training and education around the utilization of cannabis for the treatment of military-related PTSD.

Tonix Pharmaceuticals Posted Results from Pharmacokinetic Analyses of TNX-102 SL and TNX-601 CR in Advance of Virtual Poster Presentations at the American Society of Clinical Psychopharmacology

Retrieved on: 
Thursday, May 21, 2020
Articles, Life sciences, RTT, Health, Amines, Anxiolytics, Chloroarenes, Tianeptine, Fibromyalgia, Posttraumatic stress disorder, Biopharmaceutical

Dr. Sullivan continued, Based on the PK results of the TNX-601 CR study, TNX-601 CR 39.4 mg demonstrated PK appropriate for once-daily dosing with minimal food effect.

Key Points: 
  • Dr. Sullivan continued, Based on the PK results of the TNX-601 CR study, TNX-601 CR 39.4 mg demonstrated PK appropriate for once-daily dosing with minimal food effect.
  • We believe these findings support further development of TNX-601 CR, the once-daily formulation of tianeptine, in MDD, PTSD and corticosteroid-induced cognitive dysfunction.
  • Tonixs current portfolio includes biologics to prevent infectious diseases, and small molecules and biologics to treat pain, psychiatric and addiction conditions.
  • Tonixs most advanced product candidate, TNX-102 SL**, is in Phase 3 development as a bedtime treatment for fibromyalgia and PTSD.

Female Warriors Unite in Gaming

Retrieved on: 
Friday, May 15, 2020
Aftermath of war, Military, Military personnel, Veterans' affairs, Articles, Medical specialties, Wounded Warrior Project, Military psychiatry, WWP, Posttraumatic stress disorder, Discord, Army Wounded Warrior Program

Recently, WWP hosted its largest female veteran event ever, with 50 warriors coming together for a night of video games.

Key Points: 
  • Recently, WWP hosted its largest female veteran event ever, with 50 warriors coming together for a night of video games.
  • Besides video games, WWP is connecting warriors and families through trivia nights, dance lessons, arts and crafts, and talent shows.
  • "Along with connecting with other female gamers, I loved getting advice from streamers on Wounded Warrior Project's Discord channel."
  • In WWP, Natasha has found a resource to not only deal with PTSD but also connect with other female veterans.

Lief Therapeutics Announces Downtime™ Digital Anxiety Treatment Now Available Under FDA's COVID-19 Emergency Guidance

Retrieved on: 
Wednesday, May 6, 2020
Psychiatry, Anxiety disorders, Psychiatric diagnosis, Psychology, Medical diagnosis, RTT, Abnormal psychology, Anxiety, Social anxiety disorder, Generalized anxiety disorder, Posttraumatic stress disorder, Social anxiety

SAN FRANCISCO, May 6, 2020 /PRNewswire-PRWeb/ --Lief Therapeutics today announced its Downtime digital anxiety intervention is available as an adjunct treatment for Generalized Anxiety Disorder during the COVID-19 emergency.

Key Points: 
  • SAN FRANCISCO, May 6, 2020 /PRNewswire-PRWeb/ --Lief Therapeutics today announced its Downtime digital anxiety intervention is available as an adjunct treatment for Generalized Anxiety Disorder during the COVID-19 emergency.
  • For the duration of the COVID-19 emergency, physicians can prescribe Downtime to help patients manage symptoms of anxiety in conjunction with their primary treatment plan.
  • A meta-analysis of 2,086 anxiety patients found that low HRV is associated with anxiety disorders, including generalized anxiety disorder, social anxiety, PTSD, and panic.
  • Lief Rx, Lief's prescription-only device for patients, can be used as an adjunct treatment for generalized anxiety disorder after consultation with a physician.

Allied Corp. Attracting Positive Recognition and Coverage From Leading Global Media Publications

Retrieved on: 
Friday, May 1, 2020
Psychiatry, Psychiatric diagnosis, Abnormal psychology, RTT, Aftermath of war, Military, Articles, Veterans' affairs, Posttraumatic stress disorder, Comorbidity

The most likely individuals to experience someone being badly injured or killed are those that have served in the first responders or military professions.

Key Points: 
  • The most likely individuals to experience someone being badly injured or killed are those that have served in the first responders or military professions.
  • In respondents meeting the criteria for PTSD, the symptoms are chronic in nature, and associated with significant impairment and high rates of comorbidity.
  • The Allied message has been told across traditional media, social media and the internet as a result of their consistent efforts.
  • Accordingly, readers and viewers should not place undue reliance on forward-looking information, which speaks only as of the date made.